Literature DB >> 21056529

In silico experiments of single-chain antibody fragment against drugs of abuse.

Guodong Hu1, L Y Chen.   

Abstract

Three sets of in silico experiments have been conducted to elucidate the binding mechanics of two drugs, (+)-methamphetamine (METH) and amphetamine (AMP) to the single-chain variable fragment (scFv) recently engineered from anti-METH monoclonal antibody mAb6H4 (IgG, κlight chain, K(d)=11nM). The first set of in silico experiments are long time equilibration runs of scFv:drug complexes and of drug-free scFv both in the solution. They demonstrate how the solution structures of scFv deviate from its crystallographic form with or without drug molecules bound to it. They lead to the prediction that the Arrhenius activation barrier is nearly zero for transitions from the dissociated state to the bound state. The second set of in silico experiments are nonequilibrium dynamics of pulling the drug molecules out of the binding pocket of scFv and the equilibration runs for drugs to fall back into the binding pocket. They demonstrate that extra water molecules (in addition to the two crystallographic waters) exist inside the binding pocket, underneath the drug molecules. These extra waters must have been evaporated from the binding pockets during the crystallization process of the in vitro experiments of structural determination. The third set of in silico experiments are nonequilibrium steered molecular dynamics simulations to determine the absolute binding free energies of METH and AMP to scFv. The center of mass of a drug molecule (METH or AMP) is steered (pulled) towards (forward) and away from (reverse) the binding site, sampling forward and reverse pulling paths. Mechanic work is measured along the pulling paths. The work measurements are averaged through the Brownian dynamics fluctuation dissipation theorem to produce the free-energy profiles of the scFv:drug complexes as a function of the drug-scFv separation. These experiments lead to the theoretical prediction of absolute binding energies of METH and AMP that are in agreement with the in vitro experimental results.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21056529      PMCID: PMC3006299          DOI: 10.1016/j.bpc.2010.10.008

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  18 in total

1.  Steered molecular dynamics investigations of protein function.

Authors:  B Isralewitz; J Baudry; J Gullingsrud; D Kosztin; K Schulten
Journal:  J Mol Graph Model       Date:  2001       Impact factor: 2.518

2.  Calculating potentials of mean force from steered molecular dynamics simulations.

Authors:  Sanghyun Park; Klaus Schulten
Journal:  J Chem Phys       Date:  2004-04-01       Impact factor: 3.488

3.  Scalable molecular dynamics with NAMD.

Authors:  James C Phillips; Rosemary Braun; Wei Wang; James Gumbart; Emad Tajkhorshid; Elizabeth Villa; Christophe Chipot; Robert D Skeel; Laxmikant Kalé; Klaus Schulten
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

Review 4.  CHARMM: the biomolecular simulation program.

Authors:  B R Brooks; C L Brooks; A D Mackerell; L Nilsson; R J Petrella; B Roux; Y Won; G Archontis; C Bartels; S Boresch; A Caflisch; L Caves; Q Cui; A R Dinner; M Feig; S Fischer; J Gao; M Hodoscek; W Im; K Kuczera; T Lazaridis; J Ma; V Ovchinnikov; E Paci; R W Pastor; C B Post; J Z Pu; M Schaefer; B Tidor; R M Venable; H L Woodcock; X Wu; W Yang; D M York; M Karplus
Journal:  J Comput Chem       Date:  2009-07-30       Impact factor: 3.376

5.  Nonequilibrium fluctuation-dissipation theorem of Brownian dynamics.

Authors:  L Y Chen
Journal:  J Chem Phys       Date:  2008-10-14       Impact factor: 3.488

6.  A molecular model for cocaine binding by the immunotherapeutic human/mouse chimeric monoclonal antibody 2E2.

Authors:  Michael Lape; Stefan Paula; William J Ball
Journal:  Eur J Med Chem       Date:  2010-02-06       Impact factor: 6.514

7.  Synthesis, properties, and reactivity of cocaine benzoylthio ester possessing the cocaine absolute configuration.

Authors:  Shigeki Isomura; Timothy Z Hoffman; Peter Wirsching; Kim D Janda
Journal:  J Am Chem Soc       Date:  2002-04-10       Impact factor: 15.419

8.  Ligand unbinding from the estrogen receptor: a computational study of pathways and ligand specificity.

Authors:  Sofia Burendahl; Cristian Danciulescu; Lennart Nilsson
Journal:  Proteins       Date:  2009-12

9.  Crystal structures of a therapeutic single chain antibody in complex with two drugs of abuse-Methamphetamine and 3,4-methylenedioxymethamphetamine.

Authors:  Reha Celikel; Eric C Peterson; S Michael Owens; Kottayil I Varughese
Journal:  Protein Sci       Date:  2009-11       Impact factor: 6.725

10.  Steered molecular dynamics simulations reveal the likelier dissociation pathway of imatinib from its targeting kinases c-Kit and Abl.

Authors:  Li-Jun Yang; Jun Zou; Huan-Zhang Xie; Lin-Li Li; Yu-Quan Wei; Sheng-Yong Yang
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

View more
  4 in total

Review 1.  Pharmacokinetic strategies for treatment of drug overdose and addiction.

Authors:  David A Gorelick
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

2.  Insights into the mechanisms of the selectivity filter of Escherichia coli aquaporin Z.

Authors:  Guodong Hu; Liao Y Chen; Jihua Wang
Journal:  J Mol Model       Date:  2012-03-06       Impact factor: 1.810

3.  Revealing the binding modes and the unbinding of 14-3-3σ proteins and inhibitors by computational methods.

Authors:  Guodong Hu; Zanxia Cao; Shicai Xu; Wei Wang; Jihua Wang
Journal:  Sci Rep       Date:  2015-11-16       Impact factor: 4.379

4.  Structural characterization of a therapeutic anti-methamphetamine antibody fragment: oligomerization and binding of active metabolites.

Authors:  Eric C Peterson; Reha Celikel; Kuppan Gokulan; Kottayil I Varughese
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.